Scientists: Do You Really Want Your Papers Published?

Have you had any papers rejected by reputable journals recently? Or even by the less reputable journals you were forced to send the paper to when its revolutionary importance was not appreciated by earlier reviewers? If so, consider this: Perhaps—even given the enormous effort that went into submitting the grant application, preparing the protocol, and writing the paper (and even conducting the research itself)— you never really wanted the paper published in the first place. At

Written byPhillip Home
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

Have you had any papers rejected by reputable journals recently? Or even by the less reputable journals you were forced to send the paper to when its revolutionary importance was not appreciated by earlier reviewers? If so, consider this: Perhaps—even given the enormous effort that went into submitting the grant application, preparing the protocol, and writing the paper (and even conducting the research itself)— you never really wanted the paper published in the first place.

At least that’s my opinion, based on my experiences as an editor. Indeed, over the years, it has become apparent to me that much of the material submitted forpublication is actually not intended for publication. This is the only way I can explain why the style of a majority of submitted papers is not in the format of the journal concerned, and why a very high percentage of papers are rejected by reputable journals. The ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies